Chronic obstructive pulmonary disease in patients with HIV: an emerging problem
Andrew T Scourfield1, Sarah R Doffman, Robert F Miller
1Respiratory Registrar in the Department of Respiratory Medicine, University College Hospital London, London NW1 2BU.
British Journal of Hospital Medicine (London, England : 2005)
|December 10, 2014
Summary
People with well-controlled human immunodeficiency virus (HIV) now live longer lives. This review discusses chronic obstructive pulmonary disease (COPD) in HIV patients, noting similarities and crucial drug-drug interaction differences.
Area of Science:
- Pulmonology
- Infectious Diseases
- Pharmacology
Background:
- Well-controlled human immunodeficiency virus (HIV) infection is now associated with normal life expectancies.
- Physicians are increasingly diagnosing chronic obstructive pulmonary disease (COPD) in patients with HIV.
- This presents unique management challenges due to potential comorbidities and drug interactions.
Purpose of the Study:
- To review the similarities between COPD in the general population and in patients with HIV.
- To highlight key differences in the presentation and management of COPD in HIV-positive individuals.
- To emphasize the critical aspect of drug-drug interactions in this patient group.
Main Methods:
- Literature review of existing studies on COPD and HIV.
- Comparative analysis of COPD characteristics in general and HIV populations.
- Identification and discussion of significant drug-drug interactions.
Main Results:
- COPD shares many similarities in both HIV-positive and HIV-negative individuals.
- Significant differences exist, particularly concerning the increased risk and specific management considerations in HIV patients.
- Drug-drug interactions between HIV medications and COPD treatments are a major concern.
Conclusions:
- Effective management of COPD in well-controlled HIV patients requires awareness of disease similarities and differences.
- Particular attention must be paid to potential drug-drug interactions to ensure patient safety and treatment efficacy.
- Further research into optimized treatment strategies for co-existing HIV and COPD is warranted.
More Related Videos
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
3.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.3K
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
20
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
20
01:23Chronic Obstructive Pulmonary Disease I: Introduction
3
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
3
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.3K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.3K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.3K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.3K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.2K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.2K